Thirty Madison is a family of specialized healthcare brands devoted to creating exceptional outcomes for all. Each of its specialized brands is focused on a specific ongoing condition, and thoughtfully designed to support the unique needs of its community with personalized treatments and care; with Keeps for men's hair loss, Cove for migraine, Picnic for allergies, Facet for skin conditions, and NURX for sexual health.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
03/14/2022 | Series 2-H | $264,752.00 | $xx.xx | $1.11B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
446,282
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/14/2022 | Series 2-I | $194,749.00 | $xx.xx | $1.11B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
184,903
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/14/2022 | Series 2-J | $95,000.00 | $xx.xx | $1.11B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
79,064
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/14/2022 | Series 2-G | $4.59MM | $xx.xx | $1.11B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,441,662
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/14/2022 | Series 2-L | $2.46MM | $xx.xx | $1.11B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
508,513
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/14/2022 | Series 2-K | $31.89MM | $xx.xx | $1.11B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
5,293,628
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/14/2022 | Series 2-M | $72.53MM | $xx.xx | $1.11B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
6,238,563
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
06/02/2021 | Series 1 | $141MM | $xx.xx | $1.04B | Bracket Capital, Healthquest Capital, Johnson & Johnson Innovation, Mousse Partners, Northzone, Polaris Partners | |
Price per Share
$xx.xx
Shares Outstanding
7,317,220
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bracket Capital, Healthquest Capital, Johnson & Johnson Innovation, Mousse Partners, Northzone, Polaris Partners
|
||||||
08/14/2020 | Series 2-E | $8.16MM | $xx.xx | $291.04MM | Maveron, Northzone, Polaris Partners | |
Price per Share
$xx.xx
Shares Outstanding
2,499,852
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Maveron, Northzone, Polaris Partners
|
||||||
08/14/2020 | Series 2-D | $8.85MM | $xx.xx | $291.04MM | Maveron, Northzone, Polaris Partners | |
Price per Share
$xx.xx
Shares Outstanding
2,168,200
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Maveron, Northzone, Polaris Partners
|
||||||
08/14/2020 | Series 2-F | $32.16MM | $xx.xx | $194.03MM | Maveron, Northzone, Polaris Partners | |
Price per Share
$xx.xx
Shares Outstanding
7,712,174
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Maveron, Northzone, Polaris Partners
|
||||||
10/16/2018 | Series 2-C | $15.25MM | $xx.xx | $55.56MM | First Round Capita, Greycroft, Maveron, Northzone | |
Price per Share
$xx.xx
Shares Outstanding
7,753,191
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
First Round Capita, Greycroft, Maveron, Northzone
|
||||||
11/25/2017 | Series 2-A | $2.75MM | $xx.xx | $26.59MM | First Round Capital, Four Cities Capital, Greycroft, Imaginary Ventures, Maveron | |
Price per Share
$xx.xx
Shares Outstanding
4,305,276
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
First Round Capital, Four Cities Capital, Greycroft, Imaginary Ventures, Maveron
|
||||||
11/25/2017 | Series 2-B | $4.75MM | $xx.xx | $23.63MM | First Round Capital, Four Cities Capital, Greycroft, Imaginary Ventures, Maveron | |
Price per Share
$xx.xx
Shares Outstanding
3,476,042
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
First Round Capital, Four Cities Capital, Greycroft, Imaginary Ventures, Maveron
|